Translate Bio, Inc. 3 SEC Filings

Filed On	Filing
12 Aug 2021	Form 3: Sanofi, See Remarks below Holds 3,684,434 shares of Common Stock
20 Apr 2021	Form 3: Smith Brendan, Chief Financial Officer No securities owned
23 Mar 2021	Form 3: Sutherland Everett Rand, President No securities owned
03 Jun 2020	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner Holds 7,078,945 shares of Common Stock A
20 Sep 2019	Form 3: Baupost Group LLC/MA, 10% owner and 2 others Holds 17,544,239 shares of Common Stock
15 Jul 2019	Form 3: Demetri George, Director No securities owned
26 Apr 2019	Form 3: Wooster Richard, Chief Scientific Officer No securities owned
11 Apr 2019	Form 3: Plenge Robert M, Director No securities owned
03 Jan 2019	Form 3: Meyer Robert J., Director No securities owned
27 Jun 2018	Form 3: Shire Human Genetic Therapies, Inc., 10% owner and 1 other Holds 6,895,325 shares of Common Stock
27 Jun 2018	Form 3: Omega Fund IV, L.p., 10% owner and 9 others
27 Jun 2018	Form 3: Barbier Ann, Chief Medical Officer
27 Jun 2018	Form 3: Beckman Daniella, Director
27 Jun 2018	Form 3: Mrl Ventures Fund Llc, 10% owner
27 Jun 2018	Form 3: Cloghessy Paula, See Remarks Holds 51,240 shares of Common Stock
27 Jun 2018	Form 3: Atlas Venture Fund VIII, L.p., 10% owner and 2 others Holds 90,000 shares of Common Stock
27 Jun 2018	Form 3: Fenton Brian, Chief Business Officer Holds 125,495 shares of Common Stock
27 Jun 2018	Form 3: Renaud Ronald C Jr, Director Holds 369,003 shares of Common Stock
27 Jun 2018	Form 3: Hughes Owen, Director Holds 29,860 shares of Common Stock
27 Jun 2018	Form 3: Lynch Daniel, Director Holds 321,825 shares of Common Stock

Comments